OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Foundation of the Society of Retina Specialists (A company limited by guarantee, not havlng a share capital) Annual Report and Audited Financial Statements For the financial year ended 31 December 2025 Company Number: 07472064 Charity Number: 1140791

Foundatlon ol the Society Ot Retina Specialists IA ¢ompaTry Ilmlted by Euarante< not haylng a share capltsll CONTENTS Page R&forence and Admini5tratlve 5nfomiatlon Dlr•ctors' Annual R&port Statem•nt of Dirèetors. Rèsponsibilltie6 Independent Auditor's R¢port 9-12 Statemont of Flnancial Actlvlties 13 Balance Sheet 14 Stal•ment of Cash Flow5 15 Notes to the Flnanclal Statements 16-25

Foundation of the Society of Retina Specialists IA ￿MpanY IlmltÈd bywarante¢ not having a share capltall REFERENCE AND ADMINISTRATIVE INFORMATION Dlr8ctor$ Bahrarn Bodaghl Nicole Eter JeT15 Folke Kiilgaard Caroline Klaver P8010 Lanzetta Bart Leroy Anat Loewen5t8in Patricia Udaondo Mirete Reinier Schlingemann Adnan Tufail artin Sebastian Inkernagal charity Number in Enyland and Wal*s 1140791 Company Reglstration Number 7472064 Registered Office The Scalpel, 18th Floor 52 Lime Street London EC3M 7AF United Kingdom Admintstrativè Address offi￿ 17 The Old Station House 15a Main Strè8t Blackrock Co. Dublin Audttors Advantage Accountancy & Advispry Ltd Charte￿￿ Certified Accountants and StabJtory Auditors Avalon House 5-7 Cathedral Road Cardiff CF11 9HA Bankers Bank of Ireland 28 Main Street Blackrock Co Dublin Ire18nd Solkitots Charlas Russell Sp8echlys LLP S Fleet Plxe London EC4M 7RD Uniied ￿ngdorn Investment Bankers Ruffer LLP 80 ViotorH Streèt London Rathbones 30 Gresham Street London EC2V 7QN United Kingdom SW1E 5JL United Kingdom

Foundation of the Society of Retina 5peclali5t5 IA company limlted by 8uarartiee, Dot ha¥lnE a share tèpltall DIRECTORS. ANNUAL REPORT tor th8 flnan¢lal y8ar ended 31 Decembèr 2025 Th8 directors present their Diredors, Annual Report, combining the Dir$ctor5' Report and Trusteo$' R8PK)rt, and Ihe audited consolidatod financial statemen15 foi the financial year ended 31 D8cernbei 2025. The dir&¢lors have adopted the provisions of the Stalernent of Recommend8d Pradi¢e ISORPI"Ac¢ounting and Reporting by Charitses. IFRS1021 in proparing the annual report and consolidotkd financiol statsm&nls of tho group. Oblectsves and actwltles c¢1 Ihe society Foundation of the Society of Retina Speci81i5t5 IEURETINAI was incorwrated on 16 Decembor 2010 undgr thè CompaniesA¢l 2006 8s a Company Lirnited by Guarantèe and not having a Sh8re Capital. The charitabk8 company is regs18red wilh Charity Commission in the UK- Number 1140791. The obje¢lives for vthi¢h th8 charilablÈ company is estsblished ar& lo alfvan￿ educalK)n for the public benefit by lil prornoting the exchange of knowl&dge between retinal and macula 5p8¢Hlists in Europe lill 5ts"mulating and encouraging retinal and macuLa research in Europe liiil piomobng th& publication of the useful r85ulls of the charity's work livl keeping contact with similar oroups in other countrigs, and Iv) supporting retinal and macul8 resea￿￿ and pducalion by the provision of financial support andlor specialist support and advice. EURETINA has one wholly owned subsidiary, EURETINA Trading Limited. whos& princlpal activlties Include a￿angIng and hosting the annual congress of EURETINA. EURETINA Trading Limiled donates surplu5 ea¢h year to charitable company under the UK GiftAid rulas. Public benefit Th8 dir&ctors have r6ferred tts th8 guidance contained in the Charity Commission'5 general guidance Dn public btrrnefft when reviewing the souety's aims and objectives and in planning its future activities. In parbcular. the director5 consider how planned acty"vities wll contributg to t1￿ alms and objectives that have been sot. The purpD88 of EURETINA is lo ensurp the best Possible outcornes and quality of lrfe for patient5 with retinal and Macular ¢onditons. Through EURETINA'5 alms of irnproving education and standards in th1$ speclaty across Europe, pati8nts with r?tlnal and tnacula conditions and the wider public 8r8 our main bengficiaries. Tmg fundin9 of original resèarch ¢ontributes to the d8velopment of thi5 fiebJ of ophth81mology, thg 8ducation of pr8Ctthoners. and U￿rnatelY tD better patient care. Structu￿, 9overnan¢t and management The governing doCu￿nIS of the charitable company are its Memorandum and Articles ofAssociation. The Charitab￿ company has a Board ol Dir8clots. who have overall ￿SpOnsIbl11ty lor th8 prop&r m8nag8ffl&nl of th8 charitable ¢ompany'5 business. These dirE¢tors are apptsinted to a four-year term of Offi￿ on the Board. and may be re*l8¢tsd fL)i a further four-year temi. The Board is supported by an Ex8CUtive Comrnittee, which is a 5ubspt of the Board and Includes specifically the P￿Sident, Past Presidgnl, Inwrning Pr&$id&nt and Ggn&ral S8cretsry of the socièty. The Board may also appoint $ub-cornmitteos to driv8 th¢ buslness ol the society. These can include= A Programme Committ&8 AGuid&lines Committ8e A Re$earch Comtnittee An EBO Exam Committee A Sustainability Committee a A YOURS Committee Each Cornmittee is chaired by a dir8Ctor of the board and indudes non-diroctors as Committee rnembers.

Foundation of the Society of Retina Specialists IA cornparw limited by#uar3ntee. nDt havlnga 5h3re ￿pItalI DIRECTORS. ANNUAL REPORT for the ftnancial year ended 31 DecembEr2025 As EURETINAexpands i& year-￿und advty, it has str*rkgthened its foundations with th& introduction of eight $ubspecialty sections to cover key topics within the field of ￿tina. Each section has engaged the input of a selection of global experts in the grien field, who activety support fj)e B08rd, the Exe¢utive and, as necessary, the Cornmthes In their afforts to deliver top qualty and cutting-Èdge educAtion to EUREfiNA members and followers. DIre￿or5 of the ¢harttable cornpany The directo￿ of the charitsble Company are its trustees f￿ the purposes of charity law. The dlrectors are appointed by ￿SolUtion ofth& Statutory Board and must be statutory rnember5 ofthe $oci8ty. The directors who served thmghout the year, 8xcept as not8d. We￿ as follows". Bahram Bo(laghi Nicole Eter Jens Folke ￿'lIga8rd Caroline Klaver i5tsir Laidlaw Paolo Lanzetta Bart Leroy Anat Loewenstein Iresigned 07109120251 lappoint8d 07109120251 Edoardo Mid8na Patricia Udaondo ￿l￿te R8inier Schlingèmann Adnan Tufail (resigned 0710912025} Martin S8tyasllan Zinkernagel lapp)inted 07109r251 The diredors do not reti￿ by rotatb)n. There are no contracts or arrangements of any SignificaTr￿ in relabon to the business of the charitsble company or group in which the dir8Ctors had any interest. as defined in the Cornpanies Act 2006, at any durirg Ihe year. Achievements and performanc6 Eur?tilla recognises that cornpeten￿ and authority a￿ essenti81. today more than ever, in the developmènt of sustainable, effective. sclence-based diagnostic and therapeutic solutions for blindirg retinal disèases. EURETINAtakes an active role in shaping th? futu￿ of th8 subspeciaty. The Society also works tt> atldress the unmet needs of both ophthalmologists and their patients. Thè rnain actiwties undertaken in 2025. in¢luding those of the company's subsKliary, EUREfiNA Trading Limited, are set below. lal Meetlngs The annual cl)ng￿S5 is the highlight of th8 EUREfiNA calendar.Atthe annual congress, the most up to date inforwnation on new devoloptn8nts in the ffeld of r81Sna Is presented lo de￿gateS 8cros$ nurnerous modules and symposia, bringing them up to dak with prO￿￿U￿$ and developments wrfhin their own regDns and far ￿Yond. The Euretna 2025 annual wngr&ss took place In person in Paris. The meeting w25 a huge success and was extremety well sUPPOrted with 10,883 regi$tered attendees. Delegates came from 141 countrie$, which is an ongoing ￿nd￿ation ofthe wortthide re￿h and relev8n￿ ofthè society.

Foundation of the Society of Retina Specialists IA company Ilmlted by guarantee. nut havin8 a share copitall DIRECTORS. ANNUAL REPORT for the flnzncial year ended 31 December 202S Ibl Publlcatlons Ophthalfnologica, the official joumal of EURETINA, publk%hed flve onlln&188U8s in 202S. To date. yuidelines tsn three dini¢al a￿aS have been developed and published. lol Online educatlonal resour¢o8 The EURETINA website consclidates the key eduGatlonal resourGes ofthe soclety In on8 place. Th$58 include.. EURETINA On D8mand. containing an onlin$ library of conference presentalti)ns from the last ypars EURETINA Insight, a library of CME accredited e-Leaming courses EURETINA'$ Wgbinars. Debal8s, Case Clubs and ar¢hNe of recorded intgrwi8ws and p8n81 discussions with experts in ielina Talking IEulR8tina- ￿gUlar podcasts abDuI the latest retina sclencE news and current updates on EURETINA. EURETINA 8rief, a web-b858d digital ma9aine deliv&ring Up-to-date summary briets on 8 range of topics of inieresl to retinal clin￿lanS, 5pe¢ialisls and r&sear¢h8rs across gurop8 EURETINA Education Forum Portal, containing industry supported Independgnt Medical Education material EURETINA M8rnb&rs' Fotum, where rnernbtrrs can discuss retina news and no￿Ork global The aim of these resou￿5 is to provide expert-led educatDnal resource5 foi as wlde a population of retina speciali51s as possible. Idl Sc5entitl¢ research The Society has a fDmial pro￿$$ for the funding of research projects urKler the annual EURETINA Retin81 Medicir Clinical Research Funding Call. Und$r this process, applicatw)ns are Invited and reviewÈd by an ext&rro1 panel of erninentjudpes. Fundin9 for any amount up to É300,000 can be sought by dilliGian$ and researchers who ho EURETINA membgrship. Sinc8 the programm8 was establi$h8d in 2018. the sou8ty has ty¢9iV8d a high nurnb8r ol high-quality submissions and progressed wiy) eleven. In 2019, a one•off research funding r211 was made to fund dinical research tri&ls to address the best trealrnent option lor Submacular Haemorrhag8 caused by Ag8-R8lated Macular Degeneratlon. Th8 initiative was s&1 up in ¢onjunclion wrth Fight for Sight. Fundlng of GBP £1.89tn has been made avallable over 5 yearn to th& winning applicant, Klng's Collegè London. (el Obstrvership progrdmmo Tiain&e obsetveiships are available annualty for eligible, selected doctors lo spend a peri(xJ of obseFvership at an approvgd European contre of exp8rtis&. É1.500 is off8r8d lo each succ8ssfvI candld8t8. a5 w611 as access to a li$t of P￿St￿glouS training ¢èntrès. Ten observership8 were awarded in 2025. If> Membership of EU.EYE EURETINA continues to be a member of EU-EYE, tho European Mliance for Vision Research and OphlhalrrK)logy, which lobbie6 al EU level to inc￿859 political awareness and funding for ophthalmology and vision res&arch. EURETINA5UPPOrts this causo finandally and through repres&nlatiDn of EURETINA board rn8mb&rs on the EU-EfE toard. Igl EURETINAIEBO Subspeclalty Retina Exam EURETINA has developed a subspecialty r&ts"na exam in association with the European Board of Ophthalmology

Foundation of the Society of Retina Speciallsts (Acorn￿￿ limited by ¥uaranteÈ, not having 3 5h•re tapitrll DIRECTORS, ANNUAL REPORT for th financlal year ended 31 Detpmber2025 IEBOI. The first 8xam took Pla￿ In 2023. targeting reuna spe¢k8lists in Europe. The purpose of the &x8rn 18 tt)e harrnonisab'on of education across all European countries and successful candidates will be awarded a dipbrna and tiUe-. Fellow of the European Board of OphthalmolcrfJy in the subspeck%lty of Retina. Ihl Mentorshlp EURETINA is de1￿hted to contlnue its Mentorship PrDJramm8 for Rètina Speoalists, now In its third year. This Mentorship Progomme is designed to suprort the profes5ion81 developrrnt of promising retin8 specialists. Up to 5iX mentee$ are selected each year through a members, application pr0Tr5s. The programme in¢ludès carèer development skills courses aNI nelworklng opporttjntties, as well as personal tsne-lo-one sessions betyveen tnentors and rnentses.All meetings are fa¢e tt> face Whe￿ wssible and mentee travel expenses, as well as EURETINA COng￿S$ fe8s during th8 tem) ofthe programme, are ¢oVe￿d by the society. (4 EURETINA Womtn in Retina Programme The Board of EURETINA is committed to rnaking the $￿iety an Incluspie environmpnt where Its contributors and followers have equal opportunlty to thrive in the field of retina. The goal of the EURETINAWomen in Retina prtsjramme is to Trurture dwersty by giving all gend8rs equal opptsrtynity at all levels in the field of retin8. The prograrnrne also aims to educate the Mrider ophthalrnic community by supporting initiatives aimed to rèmove unfair obstac￿$ to thè professional development of promising women worklng in 8cience and care in ￿tina. The wre foundation of the Wornen in Retina programme is the belief thatthe best InnDvatDns happen when diverse people with d￿Te￿nt pe￿￿CtiveS coltaboratÈ. The initiative ￿11 help the society to harn858 these perspectives, to Challenge the way thing8 are done and allow lor them to be done better. Plan5 for futurn p•riods EURETINAwill continue to take an active anLI positNe role in shaping the fuiurè of the sub4peciaty of retina, in line with the obje¢tive5 set OLrt in its stsategic pfan. Principal rlsks and uncertainties Annual congress The msin source of income to the sDoety is its annual congress. A key risk therefo￿ to the group ￿ a failed or signffic8ndy curt&iJ8d annual confèrence and the rèsultant loss ol income thatwould arise. This Includès the risk to an 8nnual congress from &n act of terrorisrn or, as tranSpl￿d in 2020 and 2021, frorn a pandemic. Th&re 15 also the ffjk that changes In conditions occur, ovèr time, whlch reduce the attractiveness and re18vance of a large annual rneetlng dev•lop&d around a scienlffic programrne. The directors mitigate these rtsks where possible by taking out Insuran￿ for e&ch conference against Insurable risks, and maintaining sufficient reseNes to ensure the society COU￿ cx)ntinue As op?ration3 unintsrrupted in such an ev8nt while altematwe revenue sources were developed. Flnan¢ral review In Ihe year 2025, The Group generated a sury)lus of Q11,20512024.. ￿09,4321. Tre ￿sOurceS avallable to tho group and t1￿)5e expended during the year are set out in the Consolidated Statement of Financial A¢bvities. The EURETINA group is in 2 healthy ffnancial posthon. This ensure the continuèd funding of new edu(2tiDnal initiatives and resÈar¢h projects.

Foundation of the Society of Retina Specialists IA company Ilmlted by Euarantee. not havlng 3 5harE (apltall DIRECTORS. ANNUAL REPORT for the financlal year ended 31 De¢ember2025 R8seThgspolicy Th8 reserves policy lakes into considerafjon thè major risks that could affect EURETINA in the future and principalty the threat posed to the incorne of the society through 8 failed or significandy curtsiled annual Gongress whether du8 to a pandemic, competlliv8 factors, act of God, acts of teffor, or the potential withdraw81 ov8r th'me of fijnding from corporate supporters due to legislativ& and ￿gu￿810ry changes. The ieserves pollcy is designed to allow EURETINAto contr"nu& running its actriities uninterrupted for at least a 1 year perK)d, during whi¢h projacts would be re-evaluated depending on th?18vg1 of success in genorating new r8Y8nue streams. lowing at le8st a 1 year period woukl help to tninimise the risk of compromising the objectiv8s and ¢or8 8ctiwt￿s of EURETINA. On this basls. the directors consider that the ￿qUired level of ieadily usable reseNes should be £4m. This cornpares to unr8Stricted 9gn&ral res8￿e5 as shown in the audited accounts of É5.43m12024." É4.74ml. Thero Is the￿fore a surplus above the res8rve requI￿rnent ofÉ1.4Fn. The directors a￿ awar& of the surplus on unrestrided funds and ale undertaking a range of addilional activltles that should see the deploymttnt DI the retnaining 8urplus on additional ¢haritable activities in the near to mÈdium term. Inveslm8nts The investment 81ralegy 15 to achiev8 0 b8lanGed portfolio wrthin tho ￿ntsxL of a low-risk approach that primarity aims to preserve the fund's r8al c8Pital value and, in addit￿n, earn a rnodest i&lurn. Inv8StmeDts 3r8 made consideration of a 2-5 year timeframe. The return on the society's inv9Stmenl porttolio In 2025, net of fees. was 1.9%. Golng ¢on¢grn and future buslness succe$$ 11 Is exp&cted that the annual meeting will continue in a formal similar to 2025, and that the surpluses from these ebngs will 81bw EURETINAtD continue all rts Corè charitable activitles going fotward. On thi8 b8SiS the directors are confid&nl that the group will continue In op8raliorial existenc8 and that the fin8ncial statements should conbnue to be drawn up on a going concern basis. Polltl¢al donatlon5 No political donations wgre rnade during Ihe year12024." ENill. Charltable donatlon5 Charitable donations of Énil wer8 m8de durlng the year.12024.. ÉNIII. Indemnlty insuranGe The group purchased ancs Maintair￿d, Ihroughoul financial y8ar. D1￿CtOrS, and Officers. Liability Insurance in respect of thè d1￿clor8. The Audlttsr$ The auditors. AdvantagèAccountancy & Advisory Ltd {charte￿d Certifigd Accountants and Statutory AudStor51 havè indicated their willingnes5 to continue in office in a￿ordanC8 with the provisiDnS of Se¢tlon 485 of thg Companie5 Act 2006. SpeGlal provlslons rg1o¢lng to Small cornpanle$ The abov8 report has b88n prepared in acmrdance with the spacial provisions r8Lqting to small cotnpanies within Part 15 of th8 Cotnpanitss Acl 2008.

Foundatlon of the Society of Retina Specialists IAcDmpaNy limlted byguarantee. nothavlng ashare opitsll DIRECTORS. ANNUAL REPORT for the financlal year pnded 31 December 2025 Statement of relevant audlt inf0rn7ation In so far as the dlieetors a￿ aware.. thore is no re18vant aud¢( infomation (information ne8ded by the groups auditor In connection preparing the auditorfs report) of which group's auditor is unaware, and the director5 have taken all the steps that they ought to have taken as dirèctors In otderto make Ihemselves aware of ary relevant audit information 8nd tts estsblish that the groups auditor is awa￿ of that Snforrnation. Approved by the Board of Directors on 11 September 2028 and Signed on its btrhall by- Anat Loewen5tein Director

Foundation of the Soclety of Retina 5pecialistS IAcompaDy Ilrnlted by iuaraniee, not ha¥inw a share capltall STATEMENT OF DIRECTORS, RESPONSIBILITIES lor the flnan¢ial year ended 31 DeGember 2025 Th8 dirprtots (who a￿ also trustees of Fountlation of the Sodpty of Retina Spgcialists for the purpos&s of cornpany lawl are responsible for prepanng the Directors, Annual Report and Ihe con501idatsd financial statetnfrnts in accordance with applicable law and Unitsd ￿ngdorn AccDunting Stsndards Iunited Kingdom Generalty A¢¢ept8d Accounting praCt￿e). Company law requires the diiE¢tors to prepa￿ consolidabj financial statemenls for each finanrial year, which gNe a tru& and fair vi8w of the state of affairs of th& group and of the incoming re50ur¢es and application of resources, Including the inctsme and expenditure. of the group for that period. In preparing these financial statements. th8 directors 8r8 required to.. select suitable accounting policies and apply thetn consisten￿Y'. ot>serve the tnethod8 and principles in the Charities SORP". make judgements and accountlllg estimates that arg r8asonabl6 and pNdenL st8t& whether financial slalements have been prepared in accordan¢e with appllcable accounting Standards, identify those standards. and note the effect and the reasons for any rnattrial departure from thos8 Standards., and prèpare the financial statements on the going concem basis unless it is inappropriate lo p￿SUm￿ that the group will continue In operation. Th8 dir8Ctors are rgsponsiblo for keeping adequat8 accounting record5 that sufficiènt lo Show and oxpiain the group's transactions and disc1058 Wlth reasonable ac¢uracy al any lime the financial po8thon of the group and enabla them to ensure that Ihe ¢Dns0l￿aIed financial ststements comply wth the CompaniesA¢t 2006. They arg also rèsponsible for safeguarding the assets of the group and hence for taking rg8sonable Steps for the prèvantion and detect￿￿ ol traud and other irregularities. Approved by the Board of DI￿¢1916 on 11 Sept¢mber 2026 and $lgned on it$ bèha￿ by- Anèt Loewen5tein Director

Foundation of the Society of Retina Specialists IA ¢ompany limited by guarantee, not having a share ¢apital) REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF FOUNDATION OF THE SOCIEf( OF RETINA SPECIALISTS Opinion We have aUrt￿d the consolidated fin2nclal st2tements ol Foundation of the Society of Retlna Speclalists for the year ended 31 D8￿rnber 2025 which CDmpFise the Statement uf Financial Actpiities (incorporating an Income and Expenditu￿ Account), Bala￿e Sheet, Cash Fh)w Statem&nt and notss to the Finanoal St21ements, including surnmary of signffi¢arit accounting poli¢ies. The financial reporting framework that has been applied in their p￿paratIOn 1$ applicable law and United Kingdorn Accounting Standards, in¢luding FRS 102 Yhe Financial Reporting Standard applicabje in the UK and R8PUt)lic of Ireland" (United Kingdom G&nerallyAccepted A￿Ounting PraL*cel. In our opinion, when reporting In accordance with a falr pre5entstion frdmèwtsrk the financval statsments.. give 8 truè and fair view of the stat& of the gtOUPB affairs 88 at 31 De￿rnbtrr 2025 and of the Groups tncoming resources and application of resources, in¢4uding its income and expendibjre, for the y8ar then ended., have been propèrfy prepared in aCto[dan￿ with United ￿ngdorn GeneraltyAttepted Accounting Prac11￿,- and have be8n Prepa￿ in accordance with the requirements ofthe Cornpanles Act 20(￿. Basts for oplnitsn We conducted our aL¥Jit in accordance wlth International Standards on Auditing IUKI IISAS IUKII and applicable law. Our responsibilities under those stsndards a￿ fijther d&Sc￿be￿ in theAuditors' re8ponsibilities for the audit of the finanJal statements section of our reporL We are Independent of the group and parent charitable company in accordance wth the ethical requirements that a￿ relevant to our audit of the financial ststements in the UK, including the FRC'S Ethi¢31 starnda￿, and we have fijlfilled our other ethical responsibilities in accordance with these reouir8rnents. W& b81ieve that the audrt evidence we have obtsined 15 suffjtsent and appropriate to pmvicle a basi8 fDr our opinion. ¢onclu5ions tslating to gging con￿rn In auditing the consolidated financial statements, w8 have o)nduded that the directors. use of the going concem basi% of 8¢counting in the pwardlion of th8 fin8nck81 ststements is appropriate. Based on the work we have performed,. we have Aot identFfied ary rn8terfal uncèrtainties relating to events or conditions that, indiwdualjy or collectively. may cast significant doubt Dn the groups or parent Charitable ¢ornpanYs ability lo continu8 as a going La)ncem for 8 pe￿0￿ of at least twelv8 rnonths from thg date whèn thg financi81 statements are authorised for i8SUa. Our responsibilities and the ￿SpOnSIbl1[￿&S of the clirectors wth ￿sPeCt to G¥)ing concern are d8scribed In th8 relevant sections of this report. Othèr Infofftation The directors are respDnslble forthe other information. The other Infomiation comprises the infrjrmation in the Directors'Annual Report. but (bes not include the finanLyal statetnents and our Report of the Auditors thereon. Our opinion on the flnanclal statemgnts f&)e$ not cover the other infomiation and. excèpt to the extent otherwise expliciuy stated in our r8POrt, we do not expres5 any fom of assurance condusion thereon.

Foundation of the Society of Retina Speciallsts IAcompHny Slmlted by guarantse, not having a Sharo capitsll REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF FOUNDATION OF THE SOCIETY OF RETINA SPECIALISTS In conne¢tiDn with our audrt of the financial statements, our responsibility is lo read the Dth8r infomiètion 8nd. in doing 80, consider whether the other infom)aton is materially inconsistent with thè financial slaiements, or our kn￿e<1pè ot)taln8d in the 3udil or olherwise appears to b8 rnaleriglly mlsstated. Ifwe identify such materSal inconsksten¢i8s or apparent material mkq$tatementS. W8 are required to determlne whether this gwes r15e to 8 rnaterial misstatetnent in the finanaal statements themselves. If. based on the work we have perforrned. we conclude that there is a material rrfsslatement of thls othei informabon, we are required to ￿port that fact. We have nothing to report in Ihi5 regard. Oplnlon on oth8r mattgr pre5crlb•d by th8 Cpmpanies Act 2006 In our opinion. based on the Work undertak&n in the course of the audlt". th8 inforrnat50n given in thè Directors. Annual Report for th8 financial yearfor which the finanGial statements ar8 pr8pared is consistent with th8 financial slatem8nts', and the Report of the Oirectors has b88n prepared in accordance with applitable legal requirements. Matter8 on whi¢h wg aT8 requir¢d to report by exception In the light ol the knowledge and understsndlng of the company and Its Ènvironment obt8lned in the coutsè of the audit. W8 have mt idenlffied material misstalemenls in the Report of thB Director8. We have nothing to report in respect of the following mattets where the Companies Act 20[￿ requires us to report to you rf, in our opinion.. dequ2te a(tountirKJ records have not bgèn kept, or rèturns adequate for our 8udit have not b8en rec6ivgd frotn branches not visited by us.. or the financi815tstements are not in agree￿nt wkth the acEounting record5 and retums., or certain disclosures ol dire¢lors' remuneratiDn specified by law are not m8de; or We have not le￿￿ed all the information and explanations we require for our audlt. R8spon51bllltles of d0￿ctO￿$ for the fjnancial statsrnents As explained tnore fully in the Slalement of DlrÈctors' Respon$lbili1188 Set out on pago pight, the difectots (who are a150 the trustee5 of the parent charitsbl8 company for the purpD5es of charity lawl rÈsponsible for th& preparntion of the financial Statements ancl for b8ing 5atisf5ed that they give a tru8 and fair view, and for such internal ¢ontrol as thè dlre¢tors determlne nec8ssary to enabl& the preparat'on of financial slalernents that are ffft from material misststem8nt, whether due to fiBud or error. In preparing the consolidated financial statements, the directors ar8 responsit>le lor assesslng lh& groups and parent charitsble ¢ornpany 5. ability trj continue as a going concern. disclosing, as applicable, matters related to going ¢on¢gm and u51ng the going concem basis of accounting unle55 the dir8Ctot5 either in18nd to liquida18 the group or par8nl charitable company or to cease operation5, or have no raalislic altgrnalive but lo do so. Auditor's responsibilltles lor the audlt of Ihg flnanclal $t8tem8nt5 Our objectrrfes are to obtain reasonabl8 assurance atoul whether the financial statements as a whol8 aro free frorn materkal mtsstatement, whether du9 to fraud or error. and to issue an Auditors Report that includes our OPinK)n. Reasonable assurancg is a hKJh 18v81 of assurance. bul is not a guarantee that 8n audit condu¢t8d in a¢cordanc8 th ISAS IUKI will always delect a material misstatement when bt exists. Misstatements can arise from fraud or error aTr(J ale consldered rnaterial il. indiv￿UallY or in the aggtegats. they coulcl reasonabty bè expect8d to influence the 8¢onoml¢ dacisions of users taken on the b8S15 of these ¢onsolidatecS financial statements. Itregularities. including fraud. are inst8nces of non4ompliance with law& and regulations. We dÈswJn procedur8s In line wth our ￿SpOnsIbl1￿e$, ouUin&d above. to detect tnaterial misstatements in respect of irregularitie$, including fraud. 10

Foundation of the Society of Retina Specialists IA ¢ompary Ilmlt•d by guarantee. not having a share capital) REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF FOUNDATION OF THE SOCIETY OF RETINA SPECIALISTS The extent to whith our procedures a￿ capable of detecting irr8gularitTes, induding fraud 15 detailed below.. The engagemerit partner ensured that the enga9ement t&am Collectr￿ety had the appropriate Compete￿e. r2pabilities and skills to vJenttfy or recDgnisè non-complian￿ with aPpI￿able law5 8nd regulations. We obtained understsnding of the legal and regulatory frameworks appli¢2ble to the company and the sèctor in which thèy operate. We det8rmined that the following laws and regulations were most siqnificantr. The Companies Act 2006, UK corporate taxatK)n laws. empbyment legislation and health and safety legislation. We obtained an undèrstsnding of how the cotnpany are COMp￿ing with those legal and regulatory frameworks by making inquiries tts management. We corroborated our iAquiri98 through our review of legal corresp)ndence. We assessed thg suscepkn"bility of Ihe companls financial ststements to rnaterlal mi%stat8rn8nts, includ(ng how fraud might oeeur. Audit procedures perfonned by thè engagement tèam included.. rnaking enquiries of management as to where tt)ey considered the￿ wa5 susceplbilty to fraud, their knowled￿ of actual, suspected and all&g8d fraud., identifying and assessing the design &ffectiveness of controls managemènt has in place to prevent nd detectfraud., understanding how those charged wth governance ¢onsid&red and a￿d￿sSed th8 potsntial for overrEde of controls or other inappropriate influence over th2 financial reporting procfrss., perforrning analytical prOc￿ureS to Identrfy any unusual or unexpected relation5hips,' ¢hallèngitYJ assumptions and judgements made by management in ts significant accounting èst1ffl8t&s'. idèntifying and t8slngjoumal eniries. in parbcul&r sny journal entThe5 Posted wth unusual account combinations,- and ass&8sing thE extent of o)mpliance with relevant layts and regulatSons. Ther8 are Inhe￿nt risks in our audit procedures des¢rit)ed above. The more removed that laws and regulal.ons a from financial transaction. Ihe less likely rf£ is that we would become aware of non-compliance. Auditing standards also limit the 2LJdlt procedures requirèd to identify nOn￿M￿liance with laws and regulations to enquiry of the dire¢tors and other rnanagement and th¢ in8pectKJn of regulatory and legal corresponden￿. if any. Materral misstatements that arise due to fraud Can be harder to dètèctthan those that arise from erroT a5 they may involve ddiberate concealment vr collusion. A fvrthèr description of our responsibilit18s for the audit of the financial ststement5 is located on the Finanual Reporting Council's website atwww.tr¢.org.ukJauditor5responsibilities. This descripb.on forrns part of our Report of the Auditors. 11

Foundation of the Society of Retina Specialists IA wmpany Ilmltèd by 9uarantse, nol havlng a 5har8 capltall REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF FOUNDATIQN OF THE SOCIETY OF RETINA SPECIALISTS Use ot our reports This report is rnad? solely to the company's member5, as a b(Kly, in accordance with Ghapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we mighl state lo the company'5 members those matter5 we are r&quir8d to state to them in a R8POrt of the Auditors and for no other purpose. To the fullest extent permitted by law, we dts not accept or H55Utn$ responsibility lo anyDne other than the company and the ¢ompangs members as a body, for our audlt wort, for this repDrt. or for the opinion we have forrned. steph•n John Blck8rt0n1Sgnlor Statutory Auditor) for and on behalf ofAdvantage Accountan¢y &Advi50ry Ltd Ch3rtered Certifi8dAccounlanls and StalutoryAuditors Avabn House 5-7 Cathedral Road C8rdiff CF11 9FiA 111912L 12

Foundation of the Society of Retina Speciallsts IA ￿rnPanY Ilmrted by guarantèe, not having a share ¢apita CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES Ilncorporating an Income and ExpenditurÈAccountl for the financial yèar ended 31 December 2025 Unrestrlcted Total Unrestricted Total Fund5 Funds Funds FurKts 2025 2025 2024 2024 Income Notes Cha￿18b[e acbvitie8 Investments 3.058.200 32.280 3,058200 3.167.439 85,118 3,167,439 72 85,118 Tolal incomlng resources 3 090 480 3 090 480 3.252,557 3,252.557 Expenditure Charitable activlles 2 906.292 2 906.292 3.078.725 Net Ilossesygains on investrr*nts NÈt lexpendliuTrl l income 12 35.600 35.600 211,20S 211.205 209,432 209 432 Net movement in funds for the finan¢ial year 211,205 211,205 209,432 2D9,432 Recontlliation of funds- Total fun(Is brought forward Total fvnds carried foThYard 15.2 7,276.887 7.276.887 7.067.455 7 067,455 7.488.093 7,488,093 7.276,887 7,276.887 The Statement of Fjnancial Activrfles IndLtdgs all galns and Iosses recognised in the financial year. Al income and expenth1iu￿ ￿late to continuing activities. Thère is no corporation tax payable on any of the activits'es. 13

Foundation of the Society of Retina Specialists IA ¢ompany limltsd by guarantee. not having a share capital) Company Number.. DY472084 BALANCE SHEET as at 31gl Dècember 2025 2025 2025 2024 2024 Charity Group ¢harlty Group Nots5 Flxed A55ets Tangible assets Investmen15 11 4.097 4,399 12 2 986.651 2 985.652 2.928,969 2,928,970 2 990 748 2,986,652 2.933,358 2 928 970 Curront Assats D8btors 13 1,903.121 3 601 377 502.925 3 047 622 2.417,209 4,239.799 350,780 3.128,498 Cash 81 bank and in hand S.504 498 3.550 547 6,657.008 3 479,277 Cr&dltors- Amounts falling due withln one yaar 14 11.007,1531 1937.3431 12,313.4891 1892,3491 Nel Cuirènt Assets 4497 345 2.613,204 4,343,519 2.5e6,929 Total Asset5 le$$ cuttent Liabilities 7 488.093 5,599.856 7.276.887 5.515,899 Funds Unrestricted funds 7 488,093 5 599,856 7,276.887 5.515.899 Total fund3 14.1 7.488,093 5.599,856 7,276,887 5,515,899 Foundation of the Society of Retina Specialists Thadp a surplus for the year ol f83,958 after receipt of GiftAd totaling 1,760,989, frorn its trading subsidiary EU￿11￿0 Trading Ltd. These financial ststements have boen prèpared in accordance with the 5peoal provisions ￿lating to small compani88 within Part 15 of the Cotnpanigs Act 20D6. Approved by the Board of Dire¢tors and authorlsed for issue on 11 Septembei 2026 and stgned on Its behalf by Anat Logwenst8ln Dlrector 14

Foundation of the Society of Retina Specialists IA company limlted by guarantee, not havtng a share ¢apitall CONSOLIDATED CASH FLOW STATEMENTS for the financ￿1 year ended 31 December 202S 2025 2024 Cash flows from operating actlviti•$ Net movement in fvnds 211,205 209,¥2 Aijjustments for.. Gain5 and losses on investments Deprecralion charges 127.01n 1.941 13S,6001 186,129 173,832 Movements in workSng Capital.. Movement in debtors 514,088 11,306.3361 11,235,711) 959.S57 Movement in creditots Net cash provided by operations 606,119 102.322 Ca$h flows from Investlng activities Purchase ol tangible ffixed assets Net of additions, disposal proceeds and income from invesbnents Net ¢ash geneiated from invÈ5tment activilt*S 11.619) 30.6B4 15,D871 84.432 89.519 Net (de¢r￿e}rInCre8$e in rash and cash equivalents Cash and cash equtval¢nts at 1 January cash and cash equivalents at 31 DÈ¢ernber 1638,4221 4.239 799 1191,8411 3,601.377 4,239,799 Anatysis of change5 In net funds At 01.D124 Cash flow At 31.1225 Net cash Cash at bank 4,239,799 638,422 3 601,377 Total 4.239.799 638.422 3.601.377 15

Foundation of the Soclety of Retina Specialists IA company Ilmlt8d by guarantee. not havin9 a share capÈtall NOTES TO THE FINANCIAL STATEMENTS for the financial year end6d 31 Oe¢emb6r 202S GENERAL INFORMATION Foundation of the Society of Retina Specialists 18 a cornpany limited by guarantee and a regist&￿d charity, incorporated in the United Kingdom. The regiSte￿d office Df the company is The Scalpel, 18th Floor, 52 Lirne Street. Loncjon, EC3M 7AF. Th? 8dmini5trative offi¢e of the cotnpany is Office 17, The Old Station House, 15a Maln Street, Blackrock. Co. Dublln. The financial statements have been pre5eTrted in Euro IÉ) whlch Is also thg functional currency of the company. Monetary amounts in these financial statements arg round8d to the neareslfi. 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The lollDwing accounting policies have been appli&d consistently In d981ing with items which are considered rnalerial in relation to the group financi815tatements. 8a5is of prepftration The consolidated financial statetnonls of th8 group for the yeai ended 31 ￿e￿rnber 2025 have bean prepar8d on the going concern basis and in a¢cordance wth the St8lernent of Recommended Practic ISQRPI'Ac¢ounling and Rewrting by Charib'e5 prepariro their accounts in accordance with th8 Financial Reporting St&ndard applicable in the UK and Rèpublic of Ireland IFRS 1021 leffectivg 1 January 20191. and FRS 102'The Financial Reporting Standard applicable in the UK and Republic of Ireland" The charity is Publi¢ 8&nefit Entity as defined by FRS 102. Basis ot consolidalÉon The group financial statements ¢onsolidate the finan¢ial staternen15 of Foundalbn of Ihe Soclety of Retin Specialk*ts 8ncl Eu￿tIn9 Trading Limit8d. Its wholfy owned Subsidiary. No separate Statement of Financial A¢tNities has been presented for the charity alone as pertnitted by the Companigs Act 2006. The charity, the parent ¢OrnP8ny, ha5 tak6n adv8nlage of se¢tton 408 of tho Compani85 Act 2006 and has nDt included its own Slatement of Financial AcUvib"es in Ih850 financial statements. The charity's nel movement In fund$ for tho yearwas a surplus ofÉ83,95812024 deficit.. 712.3461. Funds Unresth¢l8d fund5 consist of general and designated knnds. General funds r8present amounts which ar& exppnd8bl8 at the discretion of th6 board, in fvrther8nce of tho objecliv8s of the charity. Deslgnated fund5 Cotnprise unrestricted futK£s that the board has. at Its discretion. set aside for particular purpos88. T￿se designations have an admlni$trativ8 purposo only, and do not legally strict the board's d5scretiDn lo apply the fund. IncL>me Income comprf8e$ ¢ongr8ss activity Incorne and miscellangous incorne. Income is included in the Staternent of Financial Aclivthes when the charity is legalty enlitl8d to it, 115 financial value can be quantified with reasonable ¢9rtainty and thero 1$ reasonable certainty Df ils ultimate receipt. Ineorne is accounted for on an accruals basls. ExponditurÈ All expendits1￿ Is accounted for on an accruals b85is whèn there is a legal tsr tonslruclive obligation to that expendi￿￿, It is probable setuement 1$ required ancl the amount can be measured reliably. Charitab act￿llieS include congress costs, ￿search and education costs. and 5UPPOrt and govemance ¢osts. Govemance costs ar8 thoso associat&d with consJlutlDnal and statutory requirernents. 16

Foundation of the Society of Retina Specialists IA company limltsd by guarantee, not h￿1￿9 a share capit•ll NOTES TO THE FINANCIAL STATEMENTS for the finan¢izl year ended 31 Decemf)8r 2025 Investments Investrnents a￿ initialty rerA)gnlsed at the tr&rv¢tlon value and subsequenly measured at theirfalr value at th8 balance sheet date using their closing marketvalues. Gains and losses arising on revaluaUon are included in the Ststement of FinancialAcbvthas. Trade and other dèbtors Trade and other debtors a￿ inthalty recogniserl at fairv8lue and thereafter statèd at amortised cost using the effectwe Interest method less Impairment losses for and dDubtful debts exceptwhere the effeGt of d15counting woukj be itnrnakrk21. In 5u¢h case5, the ￿￿Nable$ are stated at ¢ost less irnpairment losses for bad and doubffiil d&bts. Trade and other creditors Trade and other creilttors are inTtialty recognissd at falrvaluè and thereafter ststerl at amorbsed cost usin9 the effective interest late meth(NJ, unless the effed of disoyjunting would be immaterial, in which case they are slated at C05t. Cash and cash equivalents Cash and cash equivalents cotnprise cash at b8nk and in hand, demand dewsits wrth banks gtKI other short temi highly liquid investments witm original maturithes of three months or le$5 and bank ov8rdr8fts. In the Balance Sheet bank overdrafts ar8 shown wtthin creditors. Taxatitsn FoundatKJn of th8 sO¢￿ty of Retina Spècialists is ¢onsh￿ered to pas5 the tests set out in Paragraph 1 Schedule 6 Finan￿ Act 2010 and therefore it meets the definition of a ¢haritablg Lvmpany for UK Corw)ration Tax purposes. Accordingly. tt)e charity is potentially exempt from taxation in respect of incom8 or capital gains recewed within categories covered by Chapter 3 Part 11 Corporation TaxAct 2010 or S8¢tion 25S of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are appl￿d exclusivety to ch8ritsble purposes. The proffts ofthe subsidiary, Euretina Tradiry Limlted, are GnI￿ded to Founda￿0￿ ofthÈ Society Df Retina Specialists, therefore no amounts are chargeablè to corporation tsx. Forelgn currenciès The cOn￿lIdated financial statements are prepa￿d in Euro IQ which 15 the functbnal currency of thè group. Foreign curTrn¢y transacbons are recorded In Euro at the rate ruling on the dat8 of the transadion. Monetary assets an4 liat)ilibes denominated in foreign currencies are translated into EurD at the balance sheet dats. The resU1b￿ gains and losses are dgaltwith Sn the Staterrent of Financi81 Activthes. 17

Foundatlon of the Society of Retina Specialists IA ¢ompany IlmEt8d by guarantee, not having o share ¢apltsll NOTES TO THE FINANCIAL STATEMENTS for the finan¢lal yaar eThd￿ 31 De¢omb8r 202$ Flnanclal Instruments Flnancial o$setS Basic financial assets, induding trad8 and other receNab1È8, and cash are inih.ally recognlsed at Iransaction price (including transa¢tlon costs), unles8 the arrang8wEnl constitutes a financing transaction, the resulting financial assèt is measutyd at th8 prosgnt value of thè future re￿iptS dk5countèd at a rnarkal rale of inler85t for a similar debt instrumEnt. Skkch assets are subsequently carried at arrK>rtised wst, using the effective inteiesl method. Al the end of each ￿pOrting period, financial a88ets measured at amorbsed c05t ar& as$8ss8d for obj8cliv8 &vidence of impaim)ent. The impairrnent loss is r8co9nised in th8 Stslèment of FinancialAclivrties. Financial assets are derecognised whèn the contractual righ15 to thè cash flows frorn the asset expire or are Settled.. or subsequenuy all the risks and rewards of the ownership of the asset gre transfèrr8d to another paty., or control of the as$81 has been transferred lo another party who has th8 practical ability to unilaterally Sell the asset to an unrèlated third paty without Imposing addltbnal restrlc￿QnS on the transfer. FlnancSal 11ablll￿85 BasSc financial liabilities. including trade and other payables and bank loans are initially rectyJnis&d al transaction price, unless the arrangement constitutes a financing transaction where the re5ulling financial liability 15 measur8d at the près8nt value of thg futur& payments discountod al a rnarkÈl rale of interest for 5imSlar debt instrument. Such Ilabilltes ar8 sub5equentty carried al amorti5ed cost, usiry the effectwe interest method. Trade payables are obligations to pay for goods and servi¢es that have been acquired in the ordinary course of bu8in85s from suppli&rs. Trade payables aty ¢lassifi&d as ¢ttrrent li8bilities il payment 15 due within one year or less.1f not. thèy are presented as non-current Siabilities. Trade payables arg initla5 recognBgd at tr&Tr$aCt￿ft price and Subsequently tneasured at aM0￿$&d cost using thg eftective interest m8thod. Flnancial liabilbtie$ are d8recognL8ed when the liability is extinguishgd. that is wh9n th8 contractual obligation 15 discharged. cancelled Dr expires. Finantial assets and liabilitiès are only offset in thè balance she8t where the￿ exists a legally enforceable right to set off the recognised amoun15 and th& charity intends either lo setue on a net basis. or to realise the asset and settle the liability sitllullan8ousIy. CRITICALAGCOUNTING JUDGEMENTS AND ESTIMATES In the appliation of the charity's accounting policies, the trustees ar& required lo makè judgements, ests"mates and assumptions about the ¢arrying atnounl of assets and liabilrtie5 that are not readily apparent frorn other sources. The ?8tirnat&s and Hsso¢ialed 8ssumptDns ar& based on hisioriol experience anLI other factors that are considared to be rg18vant. Actual r88ults may differ from the estirnat8S. The e51imat&s and underlying assumptions a￿ reviewed on an ongoing basis. RÈvision5 to accounting estirnales are ￿cOgniSed in the period in which the estirnat8 15 rèvised where the ￿vision tsnly affect5 that period. or In the p&rio(5 of revision and future Per￿￿5 where the r&vi5ion affects both current and fvture periocls. In the opinion of the trustees, there a￿ no Mtical accounting ILtdgernents or 85t1[na￿On uncertainties within the ¢harity- 18

Foundation of the Society of Retina Specialists IA company limited by guarantse, not havtng a share capital) NOTES TO THE FINANCIAL STATEMENTS for the financlal yearended 31 Dè¢èmber 2025 NEf EXPENDITURE 2025 2024 Net expenditure 1$ stated aftgr charging1 Icreditingl.. Auditorfs remuneTatiDn - Audit servi￿$ 18,357 STATUS The charity is a company limited by guarantèè, not having a share capital and eonsequentty th8 liabllity of members is Ilmited, subject to 8n undertaking by each memberlo wntribute to the net assets or liabilities of the Charitable company on winding up such arnounts Js May be ￿qUired not exCe￿ing £1.27. EMPLOYEES AND REMUNERATION None of the directots received any 8moluments or unvouched expenses durlng the year12024.. Nill. In 2025 expenses attributable to Board meÈb"ngs wer8 É2.18812024'. É7,4541 in respect of seven diredors. 6.1 STAFF COSTS Th8 average monthly numb8rof employees during the yearwas as lollows.. 2025 2024 No. Stsff in charitable activities Thè a&9￿gats payroll costs of these persons We￿ as foll¢)ws'. Wage5 aThY sakri8s 335.958 278,718 Sooal security 37,723 30.873 Pon510ns 31.290 337.843 The number of higher paid employees was as follows.. 2025 2024 60,001 . É100,000 100,001- E110,000 110,001- E120.000 120,001-É130,000 130,001-f140.000 19

Foundation of the Society of Retina Specialists IA company Ilmlted by 9kharantee. not havlng a sharo ¢apltall NOTES TO THE FINANCIAL STATEMENTS for th8 financlal year pndad 31 Dec8mber 2cI25 T. INCOME 7.1 CHARITABLE ACTivrrES Unrostrtctgd RestTi¢ted Funfls Funds 2025 2024 CtsAgr8ss income Other income 2.994.200 2,994.200 3,167,439 3.058,200 3.05B,200 3.167,439 7.2 INVESTMENT INCOME Unr6Stricted Restrl¢tod Funds Funds 2025 2024 Interest income 19.644 19.644 12.636 32.280 72,331 Dividend income 32,280 85,118 EXPENDITURE 8.1 CHARITABLE AcnviTES Activltl•s directly undertakèn Grant fundlny of

etivitles

A¢tlvlty Support costs 2025 2024 Congress costs ResearGh costs EducatL)n costs 102.234 79.263 122,361 1.575.944 1,678.178 1.092.253 135 661 2,017,451 931,435 129839 1.012,991 13,500 303,857 1,026,491 1.575,944 2 906 292 3.078.725 The above expenditure was attribLrt8ble to unrÈslricted funds and included in the expenditure in 2025 are govÈrnance costs of É199.97512024.. Q87,3101 which ￿181@ dir8Ctly lo charitable ackn"vilies. See not8 9 for further detsils. 20

Foundation of the Society of Retina Specialists IA company limr￿d by guarantee, not haying a Share capitall NOTES TO THE FINANCIAL STATEMENTS for the financlal yoar en(led 31 December 2D25 ANALYSIS OF SUPPORT AND GOVERNANCE COSTS B8SFS of Apport5onment 2025 2024 Govemance costs Central oly￿e Costs Finan￿, IT, cornsullan¢y and computer costs Travel, insurance and other ¢osts Prornotion Payroll wsts 199,975 214,212 369,048 158,260 224,777 409 672 287,309 243,107 355,n)4 247,381 178,314 337,843 1649,658 Total Govemance Govèman 2024 2025 Countsl meetings and secretariat Audf(. consultancy and legal fees Company se￿ta￿al fees 1,317 197,939 718 18,976 265,247 3.087 287,310 Total 199,975 10. ANALYSIS OF GRANTS Grants to irEdivlduo15 2025 Grants to institutlons Support Costs Total 2025 Total 2024 2025 2025 Res8arch grants Education grants 1.012,990 1,012.990 859,165 9.000 888,165 13.500 1,012.990 1.026,490 21

Foundation of the Society of Retina Specialists IA ¢ompBny Ilmited by guarantso, not having a share ¢8pItsII NOTES TO THE FINANCIAL STATEMENTS ftsr the financlal yèar end•d 31 Decombgr 2025 11. TANGIBLE FIXED ASSETS GROUP Cornputsr Equlpment Cost At 01 January 2025 Additions At 31 December 2025 DÈpreciatitsn Al 01 January 2025 Charge fDr year At 31 December 2025 Net book valuè At 31 Decetnber 2025 5,087 1,619 6,706 1.941 2.609 4,097 12. INVESTMENT5 GROUP Llstsd Investmonts Valuatlon At 1 January 2025 AdditlDns Disposals Gainlloss on investments Al 31 D8c8mber 2025 Net bo¢k valu? At 31 Decernber 2025 Investsnents Total 2.928,969 2.977,272 12.946,6071 27,018 2,986,651 2,928,969 2,977,272 12.946,6071 27,018 2,986.651 2.9B6.651 2,986,651 At 31 December 2024 2,928,989 2,928,969 CHARITY Investments Subsldlary Undertaklng Shares Ll$tgd Investh)ents Totsl Valuation At 1 January 2025 Additions 2.928,969 2,977,272 12,946,607) 27.018 2,98e.fj51 2,928,970 2,977,272 12,946,607) 27.018 2,986,652 Disposals GainADSS on investments At 31 De¢emb&r 2025 Net bvok value At 31 De￿[nber 2025 2.986 651 2 986 652 At 31 08￿mber 2024 2,928,969 2,928,970

Foundation of the Society of Retina Specialists IA company limited by guarantee. not having a sh•re capital) NOTES TO THE FINANCIAL STATEMENTS lor the financial year ended 31 December 2025 12.1 ANALYSIS OF INVESTMENTS 2025 2024 Equitvès Bonds Commodities Infrdstructur8 funds Cssh held as part of the invastment wrtfollo 2,622,014 244,232 35,285 26,196 58.924 2,928,969 Total Group Equity investment Sn subsidiary 2,986 651 2,928 969 Total Charity 2 986.652 2.928,970 Dètails of 5ubsldiary undertaking At 31 December 2025 the charitable wrnpany had an interest in the following subsidiary.. Proptsrtion of voting ri9hts and 5hare$ held 100% Undertaking Eurelina Tr3Jing Llmited Prfnc5pal activffity Organising conferènces Holding 0￿Inary shatys Courttry of In¢oTporation United Kingdom The summary fifia￿l￿ p8rformanG8 of the subsidiary is.- 2025 2024 Tumovgr Cost of sales 2,994,200 1443001 3,167,439 180S,1461 Gross profit Administratnie expernsas 2.551,900 1663,6641 2.361,293 1600.3041 Profit before tsxation Tax on profrt 1.8Ba236 1,760.989 Profit forthè finandal year 1888.236 1.760,989 Fixed assets Current a588ts Current liabiliti Èk097 2,409.113 {524.9731 4,399 3,512.592 11,756,001) Net assets 1 888,237 1,760,990 Shar8holdefs funds 1888.237 1,760.990 23

Foundation of the Society of Retina Specialists IA company Ilmltsd by guarantee, not h8viTrg a share capKall NOTES TO THE FINANCIAL STATEMENTS for the 15n8ncial year ended 31 Dacomber 2025 13. DEBTQRS 2025 Group 2025 Charlty 2024 Group 2024 Charity Trade d6btor5 Amount owed from connected parknes Prepayment8 and ac¢ru8d income Other debiors Amounts Dw&d by group cornpanles (Note 161 1.669.389 216,332 17.400 36,004 73,233 114,180 2.226,700 3.096 11,758 15,919 455.163 502,925 1,903 121 2,417.209 350.780 14. CREDITORS 202S Group 2025 Charlty 2D24 Group 2024 Charity Trade credito Othèr tteditor5 Amount owed to ¢onn8Cted pprties TaxaknDn Accruals and deferred income 138,469 1,036 698.gs1 33,79T 134.90Q 1 CIC17.153 115,542 66.009 1.274,999 698,951 65,523 206,007 2,313,489 33,261 698.951 898,950 160,138 892 349 937,343 15. FUNDS 15.1 ANALY515 OF NET ASSETS BY FUND Finan¢l•l xed assets Current a55ets Curr¢nt GROUP Total Unrastrictod 2.990.748 2 990 748 5,504,498 1007 153 1,007,1S3 7,488,093 7 488 093 24

Foundation of the Society of Retina Specialists IA company Jlmited by 9uarantee, not ha¥lng a share capltall NOTES TO THE FINANCIAL STATEMENTS lor the financial year ended 31 December 2025 152 ANALYSIS OF MOVEMENTS ON FUND GROUP Balance January 2025 Transfe between funds Gain and losses Balance Dec¢mb8r Incomrny resources Resources expÈnded 2025 Deslgnated fun(ts Re$ear¢h fund Educatlonal fund 2.531.037 11.012,99DI 1294,1201 S35,084 294,120 2.053,131 UnrestrictÈd fvnd General fund 4,745.850 3.090.480 11,599,1821 1829,2041 27,017 5,434,961 Totsl Funds 7.276,887 3,090.480 2 906,292 27.017 7.488 092 16. RELATED PARTY TRANSACTtONS Th8 parent had transactions group Companies and the frjllowng arnounts are due betsveen the companies at the ye8r end.. 2025 2024 Due from group eompanies.. Eurekn"na Trading Limited 455.164 334,861 Euretina Trading Limited 1$ 100% owned by Foundation Df the Sooety of R8tina Specialists and it donates annualty its entire surplu5 to the parent company in the fomi of Gift￿￿ within nine month8 of the end of th8 financial year. 17. POST-BALANCE SHEET EVENTS Th8re hav& bean no sFgnificant events affecting the group Since the ￿ar ènd. 25